Nancy L Reinsmoen

Summary

Affiliation: Cedars-Sinai Medical Center
Country: USA

Publications

  1. doi request reprint Optimizing transplantation of sensitized heart candidates using 4 antibody detection assays to prioritize the assignment of unacceptable antigens
    Nancy L Reinsmoen
    HLA and Immunogenetics Laboratory Electronic address
    J Heart Lung Transplant 35:165-72. 2016
  2. doi request reprint Role of angiotensin II type 1 receptor-activating antibodies in solid organ transplantation
    Nancy L Reinsmoen
    HLA Laboratory, Cedars Sinai Medical Center, Los Angeles, CA 90048, United States Electronic address
    Hum Immunol 74:1474-7. 2013
  3. doi request reprint Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients
    Nancy L Reinsmoen
    Cedars Sinai Medical Center, HLA Laboratory, Comprehensive Transplant Center, Los Angeles, CA 90048, USA
    Transplantation 90:1473-7. 2010
  4. doi request reprint Antibody testing strategies for deceased donor kidney transplantation after immunomodulatory therapy
    Chih Hung Lai
    Histocompatibility and Immunogenetics Laboratory, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Transplantation 92:48-53. 2011
  5. doi request reprint Increased negative impact of donor HLA-specific together with non-HLA-specific antibodies on graft outcome
    Nancy L Reinsmoen
    1 HLA Laboratory, Cedars Sinai Medical Center, Los Angeles, CA 2 Biostatistics Core, Research Institute and General Clinical Research Center and Cardiothoracic Surgery, Cedars Sinai Medical Center, Los Angeles, CA 3 MD Anderson Medical Center, Houston, TX 4 Pathology, Cedars Sinai Medical Center, Los Angeles, CA 5 Cedars Sinai Heart Institute, Cedars Sinai Medical Center, Los Angeles, CA 6 Address correspondence to Nancy L Reinsmoen, Ph D, D ABHI HLA Laboratory, Cedars Sinai Medical Center, 8723 Alden Dr, SSB 197, Los Angeles, CA 90048
    Transplantation 97:595-601. 2014
  6. doi request reprint Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy
    Nancy L Reinsmoen
    HLA Laboratory, Cedars Sinai Medical Center, 8723 Alden Drive, SSB 197, Los Angeles, CA 90048, USA
    Transplantation 86:820-5. 2008
  7. doi request reprint Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation
    Ashley A Vo
    Comprehensive Transplant Center, Cedars Sinai Medical Center, Los Angeles, CA, USA
    Transplantation 89:1095-102. 2010
  8. doi request reprint Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies
    Mark Haas
    Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, Los Angeles, California, USA Electronic address
    Kidney Int . 2017
  9. ncbi request reprint Evolving paradigms for desensitization in managing broadly HLA sensitized transplant candidates
    Nancy L Reinsmoen
    Comprehensive Transplant Center and HLA Laboratory, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    Discov Med 13:267-73. 2012
  10. doi request reprint Intrinsic cardiac origin of human cardiosphere-derived cells
    Anthony J White
    Cedars Sinai Heart Institute, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Eur Heart J 34:68-75. 2013

Collaborators

Detail Information

Publications14

  1. doi request reprint Optimizing transplantation of sensitized heart candidates using 4 antibody detection assays to prioritize the assignment of unacceptable antigens
    Nancy L Reinsmoen
    HLA and Immunogenetics Laboratory Electronic address
    J Heart Lung Transplant 35:165-72. 2016
    ....
  2. doi request reprint Role of angiotensin II type 1 receptor-activating antibodies in solid organ transplantation
    Nancy L Reinsmoen
    HLA Laboratory, Cedars Sinai Medical Center, Los Angeles, CA 90048, United States Electronic address
    Hum Immunol 74:1474-7. 2013
    ..This review summarizes the current investigations regarding the impact of anti-AT1R antibodies in solid organ transplantation and provides insight into the humoral response in the presence of non-HLA and HLA specific antibodies...
  3. doi request reprint Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients
    Nancy L Reinsmoen
    Cedars Sinai Medical Center, HLA Laboratory, Comprehensive Transplant Center, Los Angeles, CA 90048, USA
    Transplantation 90:1473-7. 2010
    ....
  4. doi request reprint Antibody testing strategies for deceased donor kidney transplantation after immunomodulatory therapy
    Chih Hung Lai
    Histocompatibility and Immunogenetics Laboratory, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Transplantation 92:48-53. 2011
    ..The aim of our study was to identify the optimal antibody levels allowing for selection of compatible DDs for these sensitized patients...
  5. doi request reprint Increased negative impact of donor HLA-specific together with non-HLA-specific antibodies on graft outcome
    Nancy L Reinsmoen
    1 HLA Laboratory, Cedars Sinai Medical Center, Los Angeles, CA 2 Biostatistics Core, Research Institute and General Clinical Research Center and Cardiothoracic Surgery, Cedars Sinai Medical Center, Los Angeles, CA 3 MD Anderson Medical Center, Houston, TX 4 Pathology, Cedars Sinai Medical Center, Los Angeles, CA 5 Cedars Sinai Heart Institute, Cedars Sinai Medical Center, Los Angeles, CA 6 Address correspondence to Nancy L Reinsmoen, Ph D, D ABHI HLA Laboratory, Cedars Sinai Medical Center, 8723 Alden Dr, SSB 197, Los Angeles, CA 90048
    Transplantation 97:595-601. 2014
    ..The aim of our study was to determine the impact of anti-AT1R-ab and anti-donor HLA-specific antibody (DSA) on clinical outcomes...
  6. doi request reprint Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy
    Nancy L Reinsmoen
    HLA Laboratory, Cedars Sinai Medical Center, 8723 Alden Drive, SSB 197, Los Angeles, CA 90048, USA
    Transplantation 86:820-5. 2008
    ....
  7. doi request reprint Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation
    Ashley A Vo
    Comprehensive Transplant Center, Cedars Sinai Medical Center, Los Angeles, CA, USA
    Transplantation 89:1095-102. 2010
    ....
  8. doi request reprint Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies
    Mark Haas
    Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, Los Angeles, California, USA Electronic address
    Kidney Int . 2017
    ....
  9. ncbi request reprint Evolving paradigms for desensitization in managing broadly HLA sensitized transplant candidates
    Nancy L Reinsmoen
    Comprehensive Transplant Center and HLA Laboratory, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    Discov Med 13:267-73. 2012
    ....
  10. doi request reprint Intrinsic cardiac origin of human cardiosphere-derived cells
    Anthony J White
    Cedars Sinai Heart Institute, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Eur Heart J 34:68-75. 2013
    ..The origin of CDCs remains unclear: are these cells endogenous to the heart, or do they arise from cells that populate the heart via blood-borne seeding?..
  11. doi request reprint Detection of intracellular cytokines
    Nancy L Reinsmoen
    HLA Laboratory, Cedars Sinai Medical Center, Los Angeles, CA, USA
    Methods Mol Biol 1034:353-8. 2013
    ....
  12. doi request reprint Pretransplant donor-specific and non-specific immune parameters associated with early acute rejection
    Nancy L Reinsmoen
    David Geffen School of Medicine at UCLA, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Transplantation 85:462-70. 2008
    ..The aim of our studies was to determine whether pretransplant immune parameters were associated with posttransplant early acute rejection, unstable creatinine courses, and poor graft outcome...
  13. ncbi request reprint A 3 Center Study Reveals New Insights into the Impact of NonHLA Antibodies On Lung Transplantation Outcome
    Nancy L Reinsmoen
    1 Cedars Sinai Medical Center, HLA Laboratory, Comprehensive Transplant Center, Los Angeles, CA 2Biostatistics Core, Research Institute and General Clinical Research Center and Cardiothoracic Surgery, Cedars Sinai Medical Center, Los Angeles, CA 3 University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 4Pulmonary, Critical Care Medicine, Comprehensive Transplant Center, Cedars Sinai Medical Center, Los Angeles, CA 5University of Texas Health Science Center, San Antonio, TX 6Address correspondence to Nancy L Reinsmoen, Ph D ABHI, HLA Laboratory, Cedars Sinai Medical Center, 8723 Alden Drive, SSB 197, Los Angeles, CA 90048
    Transplantation . 2016
    ..The aim of our study was to determine the impact of AT1R and ETAR antibodies on graft outcome in lung transplantation...
  14. doi request reprint Non-human leukocyte antigen-specific antibodies in thoracic transplantation
    Nancy L Reinsmoen
    HLA Laboratory, Cedars Sinai Medical Center, Comprehensive Transplant Center, Los Angeles, California, USA
    Curr Opin Organ Transplant 21:350-4. 2016
    ..It is suggested that HLA antibodies and non-HLA antibodies collaborate together to impact graft outcome. This review focuses on the latest findings on antibodies against these non-HLA antigens in thoracic organ transplant...